Shares of Chemed Corp. (CHE) surged 7.07% in Thursday's pre-market trading, following the company's better-than-expected fourth-quarter earnings results.
The healthcare services provider reported adjusted earnings per share of $6.83 for the quarter ended December 31, beating analysts' average estimate of $6.78. Revenue grew 9.2% year-over-year to $639.99 million, also surpassing expectations of $636.10 million.
Chemed's solid quarterly performance, highlighted by earnings and revenue beats, appears to be the primary driver behind the stock's significant pre-market rally. The company's strong results underscore its continued growth momentum and operational efficiency.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.